» Articles » PMID: 18768880

PIR-B-deficient Mice Are Susceptible to Salmonella Infection

Overview
Journal J Immunol
Date 2008 Sep 5
PMID 18768880
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Paired Ig-like receptors of activating (PIR-A) and inhibitory (PIR-B) isoforms are expressed by many hematopoietic cells, including B lymphocytes and myeloid cells. To determine the functional roles of PIR-A and PIR-B in primary bacterial infection, PIR-B-deficient (PIR-B(-/-)) and wild-type (WT) control mice were injected i.v. with an attenuated strain of Salmonella enterica Typhimurium (WB335). PIR-B(-/-) mice were found to be more susceptible to Salmonella infection than WT mice, as evidenced by high mortality rate, high bacterial loads in the liver and spleen, and a failure to clear bacteria from the circulation. Although blood levels of major cytokines and Salmonella-specific Abs were mostly comparable in the two groups of mice, distinct patterns of inflammatory lesions were found in their livers at 7-14 days postinfection: diffuse spreading along the sinusoids in PIR-B(-/-) mice vs nodular restricted localization in WT mice. PIR-B(-/-) mice have more inflammatory cells in the liver but fewer B cells and CD8(+) T cells in the spleen than WT mice at 14 days postinfection. PIR-B(-/-) bone marrow-derived macrophages (BMMphi) failed to control intracellular replication of Salmonella in vitro, in part due to inefficient phagosomal oxidant production, when compared with WT BMMphi. PIR-B(-/-) BMMphi also produced more nitrite and TNF-alpha upon exposure to Salmonella than WT BMMphi did. These findings suggest that the disruption of PIR-A and PIR-B balance affects their regulatory roles in host defense to bacterial infection.

Citing Articles

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice.

Lee H, Manangeeswaran M, Lewkowicz A, Engel K, Chowdhury M, Garige M JCI Insight. 2022; 7(3).

PMID: 35132958 PMC: 8855830. DOI: 10.1172/jci.insight.151420.


PIR-B Regulates CD4 IL17a T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.

Uddin J, Tomar S, Sharma A, Waggoner L, Ganesan V, Marella S Cell Mol Gastroenterol Hepatol. 2021; 12(4):1479-1502.

PMID: 34242819 PMC: 8531983. DOI: 10.1016/j.jcmgh.2021.06.013.


Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Deng M, Chen H, Liu X, Huang R, He Y, Yoo B Antib Ther. 2021; 4(1):16-33.

PMID: 33928233 PMC: 7944505. DOI: 10.1093/abt/tbab002.


IL-7 Enables Antibody Responses to Bacterial Polysaccharides by Promoting B Cell Receptor Diversity.

Dickinson G, Levenson E, Walker J, Kearney J, Alugupalli K J Immunol. 2018; 201(4):1229-1240.

PMID: 30006375 PMC: 6085875. DOI: 10.4049/jimmunol.1800162.


An Unmutated IgM Response to the Vi Polysaccharide of Typhi Contributes to Protective Immunity in a Murine Model of Typhoid.

Pandya K, Palomo-Caturla I, Walker J, Sandilya V, Zhong Z, Alugupalli K J Immunol. 2018; 200(12):4078-4084.

PMID: 29743315 PMC: 6033073. DOI: 10.4049/jimmunol.1701348.


References
1.
Sinha K, Mastroeni P, Harrison J, de Hormaeche R, Hormaeche C . Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun. 1997; 65(4):1566-9. PMC: 175172. DOI: 10.1128/iai.65.4.1566-1569.1997. View

2.
Kiyotaki M, Cooper M, Bertoli L, Kearney J, Kubagawa H . Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells. J Immunol. 1987; 138(12):4150-8. View

3.
Mittrucker H, Kohler A, Mak T, Kaufmann S . Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol. 1999; 163(12):6769-76. View

4.
HAYAMI K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, Ohyama Y . Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem. 1997; 272(11):7320-7. DOI: 10.1074/jbc.272.11.7320. View

5.
Hotchkiss R, Osmon S, Chang K, Wagner T, Coopersmith C, Karl I . Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005; 174(8):5110-8. DOI: 10.4049/jimmunol.174.8.5110. View